Showing results (11-20 of 138) with videos related to
Sort By:
Pageof 14
Frontiers in Psychology|June 7, 2021
The Role of Suppression and the Maintenance of Euthymia in Clinical SettingsEmanuele Maria Merlo, Anca Pantea Stoian, Ion G Motofei, et al.Metabolic Syndrome and Related Disorders|December 30, 2021
Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught UsAnca Pantea Stoian, Peter Kempler, Thomas Stulnig, et al.Diagnostics (Basel, Switzerland)|August 26, 2022
Clinical Model for the Prediction of Severe Liver Fibrosis in Adult Patients with Type II Diabetes MellitusOvidiu Paul Calapod, Andreea Maria Marin, Anca Pantea Stoian, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|September 3, 2025
Continuous Glucose Monitoring During Recreational Diving in Type 1 Diabetes: Navigating Clinical and Technical UncertaintiesDjordje S Popovic, Theocharis Koufakis, Dimitrios Patoulias, et al.Journal of Cardiovascular Pharmacology and Therapeutics|July 4, 2020
Incretin-Based Therapies Role in COVID-19 Era: Evolving InsightsAnca Pantea Stoian, Nikolaos Papanas, Martin Prazny, et al.Journal of Diabetes and Its Complications|November 2, 2023
Comparative evaluation of LDL-CT, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitusIoana Păunică, Andrada Doina Mihai, Simona Ștefan, et al.Nutrients|May 27, 2023
Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative ReviewArrigo F G Cicero, Federica Fogacci, Anca Pantea Stoian, et al.Medicina (Kaunas, Lithuania)|March 27, 2025
SGLT-2i-A Useful Tool for Real-Life Metabolic and Body Weight Control in Type 2 Diabetes Mellitus PatientsMihaela-Simona Popoviciu, Teodor Salmen, Delia Reurean-Pintilei, et al.Metabolites|July 27, 2022
Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future DirectionsBala Mohan Sivani, Mahmoud Azzeh, Rajashree Patnaik, et al.Journal of Diabetes and Its Complications|June 10, 2023
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trialsDimitrios Patoulias, Djordje S Popovic, Anca Pantea Stoian, et al.Pageof 14